<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/951E6878-2797-4CF8-958C-D27AB6E74FFD"><gtr:id>951E6878-2797-4CF8-958C-D27AB6E74FFD</gtr:id><gtr:name>University of Nevada</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/430ABEF3-2F94-4B47-A8DB-E521642AA1E5"><gtr:id>430ABEF3-2F94-4B47-A8DB-E521642AA1E5</gtr:id><gtr:name>University of Wisconsin Madison</gtr:name><gtr:address><gtr:line1>University of Wisconsin</gtr:line1><gtr:line4>Madison</gtr:line4><gtr:line5>Wisconsin</gtr:line5><gtr:postCode>WI 53706</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/17BF6965-68C3-4560-8BC2-28AC2D489890"><gtr:id>17BF6965-68C3-4560-8BC2-28AC2D489890</gtr:id><gtr:name>University of Virginia</gtr:name><gtr:address><gtr:line1>P.O. Box 3818</gtr:line1><gtr:postCode>22903</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:department>Sch of Molecular Sciences</gtr:department><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/951E6878-2797-4CF8-958C-D27AB6E74FFD"><gtr:id>951E6878-2797-4CF8-958C-D27AB6E74FFD</gtr:id><gtr:name>University of Nevada</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/430ABEF3-2F94-4B47-A8DB-E521642AA1E5"><gtr:id>430ABEF3-2F94-4B47-A8DB-E521642AA1E5</gtr:id><gtr:name>University of Wisconsin Madison</gtr:name><gtr:address><gtr:line1>University of Wisconsin</gtr:line1><gtr:line4>Madison</gtr:line4><gtr:line5>Wisconsin</gtr:line5><gtr:postCode>WI 53706</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/17BF6965-68C3-4560-8BC2-28AC2D489890"><gtr:id>17BF6965-68C3-4560-8BC2-28AC2D489890</gtr:id><gtr:name>University of Virginia</gtr:name><gtr:address><gtr:line1>P.O. Box 3818</gtr:line1><gtr:postCode>22903</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F58BCA0E-FFAA-44F1-AECF-C1A41A899652"><gtr:id>F58BCA0E-FFAA-44F1-AECF-C1A41A899652</gtr:id><gtr:firstName>Alan</gtr:firstName><gtr:surname>Cockayne</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/DFD21521-A69F-49FD-B9B2-4A71B9D61673"><gtr:id>DFD21521-A69F-49FD-B9B2-4A71B9D61673</gtr:id><gtr:firstName>Adam</gtr:firstName><gtr:surname>Roberts</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/CAB13A88-E7C2-42DB-973E-3D6A5E305AF7"><gtr:id>CAB13A88-E7C2-42DB-973E-3D6A5E305AF7</gtr:id><gtr:firstName>Nigel</gtr:firstName><gtr:surname>Minton</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/474C7EE5-843D-4917-9D5B-88CFF82C75B0"><gtr:id>474C7EE5-843D-4917-9D5B-88CFF82C75B0</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:surname>Mullany</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0601176"><gtr:id>34D87AEA-AB14-4C49-8B10-3B0444B62D91</gtr:id><gtr:title>Understanding the Molecular Basis of Virulence in Clostridium difficile.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0601176</gtr:grantReference><gtr:abstractText>There are currently heightened public concerns over infection rates in UK hospitals, and in particular those caused by so called ?superbugs? that have become resistant to available antibiotics. One such bug is Clostridium difficile. It causes debilitating diarrhoea, which in extreme cases can kill. It mainly affects the elderly. As this proportion of the population is increasing, the disease is becoming more common. Worryingly, a new, even more deadly variant has now arrived in Europe from North America. Aside from the human suffering, it costs the NHS over #402 million per year, and now is responsible for more deaths per year than MRSA. To control infections, we need to understand how an organism causes disease. Under Wellcome Trust sponsorship, the complete genome sequence of the organism (ie., its genetic blueprint) has been determined. However, whilst we now know the sequences of every gene in the C. difficile chromosome, we do not understand what they are doing. The best way of working out what genes do, is to mutate them (make them non-functional) and assess the consequences. Until now this has not been possible. We have now developed the tools needed, and wish to use them to better understand how this bug causes disease. This should eventually lead to better ways of controlling the disease.</gtr:abstractText><gtr:technicalSummary>Clostridium difficile-associated diarrhoea (CDAD) has become the most frequent nosocomial infection in many European hospitals, causing twice as many deaths in the UK during 2003 than MRSA. Its impact is considerable, both in terms of human suffering and costs of disease management. Taking the latest incidence figures (51,690 in 2005), it can be estimated to be costing England &amp;amp; Wales over #400 million per annum. A number of factors have contributed to this escalation. The proportion of the population in the main high-risk group, the elderly, is rapidly rising (over 65?s will double by 2050). More worrying has been the steady increase in strains exhibiting increased virulence. In 2004, the situation was exacerbated by the arrival in Europe of a new hypervirulent strain (ribotype 027) from N. America, where it has caused a large increase in CDAD incidence and associated deaths. In Stoke Mandeville Hospital, where first reported in the UK, two outbreaks of C difficile have affected 334 patients, killing at least 33. The inexorable rise in C. difficile incidence shows no sign of abating. It is imperative that more effect countermeasures are devised. However, pathogenesis is extremely poorly understood. As a result of our efforts, all of the elements needed to make significant progress in better understanding virulence in C. difficile are now in place. Thus, we have developed: (i) reproducible methods for the introduction DNA into C. difficile; (ii) a universal, clostridial, gene knock-out system, the ClosTron, which allows, for the first time, the rapid generation of stable, directed genes knock-outs, and; (iii) a transposon mutagenesis system with which random mutants may, for the first time, be readily generated. Moreover, at the projects initiation we will have in place: (iv) the animal model; (v) a new microarray for studies with both strain 630 AND the 027 strain, and; (vi) the genome sequences of CD 630 and a 027 strain. The overall aim of this project is, therefore, to capitalise on our unique expertise and resource to embark on a programme of work designed to unequivocally identify those C. difficile factors that are important in disease and to begin to determine both how they are regulated and how they contribute to virulence. Our programme of mutagenesis will lead to the identification of those factors (structural and regulatory) that are most important in disease, allowing a subsequent more in depth analysis of their role in pathogenesis to be initiated.</gtr:technicalSummary><gtr:fund><gtr:end>2013-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1590252</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Virginia (UVa)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>University of Virginia Health System</gtr:department><gtr:description>Clostrium difficile and host interactions</gtr:description><gtr:id>F46C2870-254E-4EEB-9507-5CF7477CA33D</gtr:id><gtr:impact>Manuscript submitted to Mbio.

Carrie A. Cowardin 1, Sarah A. Kuehne 2, Erica L. Buonomo1, Chelsea S. Marie 3, Nigel P. Minton 2, William A. Petri, Jr. 1,3 * Inflammasome Activation Contributes to IL-23 Production in Response to Clostridium difficile

1. Microbiology, Immunology and Cancer Biology, University of Virginia, Charlottesville, VA, United States
2. Nottingham Digestive Diseases Centre, University of Nottingham, Nottingham, United Kingdom
3. Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, VA, United States</gtr:impact><gtr:outcomeId>545e35b0ee3457.14353864-1</gtr:outcomeId><gtr:partnerContribution>The bulk of the work undertaken in USA. Initially the postdoc involved was trained at Nottingham in how to manipulate C. difficile. Mutants made at Nottingham were transferred to the USA for their experiments under a suitable MTA.</gtr:partnerContribution><gtr:piContribution>The pro-inflammatory cytokine IL-23 is pathogenic during Clostridium difficile infection (CDI), as mice deficient in IL-23 via genetic knockout or by antibody depletion are significantly protected from death (Buonomo, 2013). We sought to determine how the obligate anaerobe C. difficile induces IL-23 to better understand how host recognition of this pathogen influences the initial inflammatory response to shape the course of disease. This
is particularly relevant in light of recent findings suggesting that the host response to infection correlates more closely with disease severity than pathogen burden.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Wisconsin-Madison</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Molecular Genetics Clostridium botulinum</gtr:description><gtr:id>6198237A-DB6D-4725-B336-0E8D7F75292F</gtr:id><gtr:impact>Joint paper published on creation of a C.botulinum mutant</gtr:impact><gtr:outcomeId>68293508BAD-1</gtr:outcomeId><gtr:partnerContribution>Demonstration of tool applications in C. botulinum</gtr:partnerContribution><gtr:piContribution>Supply and design of mutational plasmids</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nevada</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Sporulation in Clostridium difficile.</gtr:description><gtr:id>A0673AF0-56D2-4B38-A6B2-3B0EE1DD4163</gtr:id><gtr:impact>A rant has been submitted between Nottingham and Las Vegas to the National Institutes for Health, entitled &amp;quot;Prophylaxis of Clostridium difficile infection&amp;quot; with the. We are expecting a subcontract totaling $270,777</gtr:impact><gtr:outcomeId>545e389ba83966.58209729-1</gtr:outcomeId><gtr:partnerContribution>The Ernesto Abel-Santos have developed synthetic bile salts (CamSA) that specifically inhibit Clostridium difficile spore germination. These are being assessed in terms of their in vitro potencies and in vivo efficacies.</gtr:partnerContribution><gtr:piContribution>Nottingham has supplied transposon mutant libraries , under a suitable MTA, to allow the Abel-Santos lab to screen for random mutants affected in germination.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Profiled at MRC Website PERSPECTIVES: Annual Review 2010/2011</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E10E8634-59A5-43A8-83DC-E6CA47A309C8</gtr:id><gtr:impact>Perspectives tells the stories of MRC-funded scientists across the UK and Africa who have made some of the most compelling discoveries of 2010/11 by thinking about medical research challenges from a new angle.



Not Quantifiable</gtr:impact><gtr:outcomeId>fqkER7QMny5</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>University Vision Magazine</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>7E2DBB17-3128-42D9-864D-3EE85AB093BF</gtr:id><gtr:impact>An article entitled &amp;quot;Beating The Bug&amp;quot;, was &amp;quot;spotlighted&amp;quot; in the Spring 2008 edition of the University of Nottingham publication &amp;quot;Vision&amp;quot;

magazine article promoting research</gtr:impact><gtr:outcomeId>C6F5B4970D0</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC East Midlands Interview</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>73C3A892-927B-4010-BDEA-F45BA08BA180</gtr:id><gtr:impact>Interview 19th January 2009 on BBC East Midlands Today about research on C.difficile being undertaken at Nottingham and on 27th January about Bioenergy

Raised public awareness of C. diff and biofuels research at the University of Nottingham</gtr:impact><gtr:outcomeId>D1BAF57C80D</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Nature Press Briefing at British Science Festival</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>88B91CAE-1B8F-4190-8E1B-8C0D96D65049</gtr:id><gtr:impact>Press briefing organised by Nature. Sarah Kuehne and Steve Cartman presented the findings of our Nature paper to approximately 10 representaives of the press.

This activity was enhanced by news coverage to a public audience.</gtr:impact><gtr:outcomeId>hCwV1AuLaUU</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SBRC &amp; C1net Outreach Activity - Mayfest 2015, Community Open Day, University of Nottingham</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>775672A2-50AA-4D38-86C9-AA82B9485C29</gtr:id><gtr:impact>Mayfest is UoN community open day, activities are to raise public awareness as well as helping to get children involved in science. SBRC &amp;amp; C1net stand with activities including making bacteria from plasticene, make your own bioreactor, molymods and an anaerobic cabinet to demonstrate what its like working in a lab. This was highlighted at the School of Life Sciences all staff meeting. Feedback about the session was excellent.</gtr:impact><gtr:outcomeId>56cddeb21a9da6.65771822</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Parliamentary Science Committee</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>40975E6A-734C-4ECB-88A6-104E71D55CB0</gtr:id><gtr:impact>Spoke at Parliamentary and Scientific Committee at special session on New Diseases and Renewed Threats. Title of talk &amp;quot; 'difficile' by name, 'difficile' by nature. Talk published in Whitsun 2008 issue of &amp;quot;Science in Parliament&amp;quot;, page 26-27.

Talk published in Whitsun 2008 issue of &amp;quot;Science in Parliament&amp;quot;, page 26-27.</gtr:impact><gtr:outcomeId>41D03BD226C</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:url>http://www.scienceinparliament.org.uk/</gtr:url><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SBRC Outreach Activity - University of Nottingham's Research Showcase</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>487855B3-7B12-4F75-8CA8-7A5AA70DC783</gtr:id><gtr:impact>this was an opportunity for researchers to share their passion for their work, practice their presentation skills and engage with the wider public.&amp;nbsp; Visitors to the Showcase have the opportunity to meet with world-leading researchers of the future, hear about their research and question them about what it means for society. A PhD student from the SBRC won 3rd Prize in the poster competition with her poster titled: Using Jumping Genes to Understand Bacterial Genetics.</gtr:impact><gtr:outcomeId>56cde14889b056.12225658</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:url>https://www.nottingham.ac.uk/graduateschool/events/researchshowcase/2015-winners.aspx</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBSRC Business Magazine</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B2AA7D05-8003-4771-8964-B9E2622A3701</gtr:id><gtr:impact>Work on Clostridia was promoted in 2 articles in the quarterly, corporate magazine, &amp;quot;BBSRC Business&amp;quot;, namely, &amp;quot;The Dawning of a New Era&amp;quot; pg. 12 and &amp;quot;Difficult by Name, Difficult by Nature&amp;quot; pgs. 18-19

Professor Minton's work on Clostridia was promoted.</gtr:impact><gtr:outcomeId>51D6434CF71</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CHAI charity dinner, London, September 2010</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8906588A-4E2F-44C8-95A2-2C70746A4A3B</gtr:id><gtr:impact>&amp;pound;27000 was raised to go towards research.

Promotion and money raised.</gtr:impact><gtr:outcomeId>54622f902c5d32.51759398</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.nottingham.ac.uk/impactcampaign/campaignpriorities/healthandwell-being/hospitalsuperbugs/hospitalsuperbugs.aspx</gtr:url><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SBRC Outreach - Notts TV Interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>DC7D5760-BEE1-449A-8C2D-F3E95493E058</gtr:id><gtr:impact>Dr Sarah Kuehne gave a TV interview with local TV station - Notts TV. Sarah gave an interview about C. dIff infection in Hospitals, how we can combat the superbug and her research at the SBRC and the importance of washing our hands properly. Raising awareness to a wide audience.
Over ~&amp;nbsp;20,0000&amp;nbsp;people tune in to watch Notts TV.</gtr:impact><gtr:outcomeId>56cde40a11b293.23734650</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:url>http://nottstv.com/five-deaths-linked-to-super-bug-at-nottingham-hospitals/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SBRC &amp; C1net Outreach Activity at British Science Association's Science in the Park, Nottingham</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>EBA6BBA3-0F87-44A9-B9C5-7A973954473A</gtr:id><gtr:impact>Science in the Park is a local event ran by the Nottinghamshire Branch of the British Science Association for members of the public. Activities on Making bacteria from Plasticine, make your own bioreactor and c1 gases using molymods. Raise awareness of the SBRC and public engagement. Over ~500 attendees from families, schools, public other academics.</gtr:impact><gtr:outcomeId>56cdd860b28148.80532388</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://nottsbsa.org/science-in-the-park-2015/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Visit by Secretary of State for Health to NIHR BRU in GI disease</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8900F6BA-2644-4335-A019-164AB4E3CBA8</gtr:id><gtr:impact>Visit to Nottingham's BRU in GI Disease on March 7th by Department of Health Secretary of State to announce the call for renewal's of BRU's across the country. As part of a visit, a poster wqs presenting describing our C. difficile in 'lay' terms

This also involved TV coverage to the public</gtr:impact><gtr:outcomeId>EQeJL6UTo1b</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Special Public Sessions at International ClostPath Meetings</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>32E147BE-8A95-4046-9511-C19E87AD2B39</gtr:id><gtr:impact>Special sessions for the public have been held at the International ClostPath meetings in Nottingham in 2006 (http://www.clostridia.net/clostpath2006/public.html), and in Rome in 2009 (http://www.clostridia.net/rome/programme.html).

Impacts not quantifiable</gtr:impact><gtr:outcomeId>DDD17380CE2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.clostridia.net/rome/programme.html</gtr:url><gtr:year>2006,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SBRC &amp; C1net Outreach Activity - Cambridge HE Getaways,  Visit to The University of Nottingham</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3A4C292A-5CD0-465A-BCD5-4C86B603705B</gtr:id><gtr:impact>Outreach event organised by UoN Widening Participation group for Yr 10s within the Cambridge area to enhance their choice on coming to study at University. DNA extraction from strawberries PhD students explained how and why they got into science. Another PhD student gave a presentation on his PhD work and how and why he got into science also ran a practical called 'design your own plasmid'.</gtr:impact><gtr:outcomeId>56cddcac9835a7.58414324</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Smooth Radio Interview</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>92F8F0E9-4CD4-49E1-8577-85BA4F4743B8</gtr:id><gtr:impact>Interview on Smooth Radio about research on C.difficile being undertaken at Nottingham

The interview on C Diff was broadcast to the public - this radio station has up to 4.6m listeners a week</gtr:impact><gtr:outcomeId>DD2644B00E9</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Various Press Releases concerning Nature publication</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>AA4B3685-BAF1-4A04-9E7A-077B559F57BA</gtr:id><gtr:impact>A number of press releases were made in relation to our Nature paper. This informed a wide audience through the internet.
http://www.mrc.ac.uk/Newspublications/News/MRC007231

http://www.nature.com/scibx/journal/v3/n37/full/scibx.2010.1112.html

http://www.nottingham.ac.uk/news/pressreleases/2010/september/cdifftoxinminton.aspx

http://www.physorg.com/news203949517.html

Not Aware of any specific impacts.</gtr:impact><gtr:outcomeId>WVTtrdWNRqk</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBSRC Special Newsletter</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>52605FED-2C38-48FC-817C-D168ECB2C2A8</gtr:id><gtr:impact>Work was promoted in the corporate brochure &amp;quot;The Bioscience Behind: Tackling Superbugs. http://www.bbsrc.ac.uk/publications/corporate/magazine/2007/0704_business.html

Magazine article informing readers about research into tackling superbugs - promoted Professor Minton's Work</gtr:impact><gtr:outcomeId>5BE9F5A1F7F</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://webarchive.nationalarchives.gov.uk/20080111011407/http://www.bbsrc.ac.uk/publications/corporate/bioscience_behind_superbugs.pdf</gtr:url><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Society for General Microbiology Public Engagement session on &quot;Superbugs&quot;</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>053EF1C3-72EF-4191-A925-6A8062E27867</gtr:id><gtr:impact>150 members of the public attended a special public session to watch a play about superbugs and were then invited to ask questions of an expert panel.

Excellent feedback was received by the society re this event</gtr:impact><gtr:outcomeId>evDPnQBizAC</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Official Opening of the Nottingham Digestive Diseases Centre NIHR Biomedical Research Unit (NDDC BRU)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A5116C2A-0E82-41CC-A33C-80352331F2F0</gtr:id><gtr:impact>A poster was presented at the official opening of the Nottingham Digestive Diseases Centre NIHR Biomedical Research Unit (NDDC BRU) - &amp;quot;BEATING THE SUPERBUG - Clostridium difficile&amp;quot; by Sarah Kuehne, Steve Cartman, Alan Cockayne and Nigel P Minton, which described in lay terms the work that was ongoing within the group. Opening attended by Major Of Nottingham, Leslie Ash, and other members of the public and patient groups.

This was a news story on East Midlands Today, a news programme on BBC1 and raised awareness of the research working going on at the University of Nottingham.</gtr:impact><gtr:outcomeId>RjAcHSZHs6T</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>217000</gtr:amountPounds><gtr:country>Japan</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Astellas: Analysis of the Effects of Fidaxomicin on Spores</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>Astellas Pharma</gtr:fundingOrg><gtr:fundingRef>CDS-FDX-2012-MINTON-study</gtr:fundingRef><gtr:id>FC9C872D-6E19-498C-928A-D1E6B9C60E09</gtr:id><gtr:outcomeId>545cfd22a5e6a5.20079195</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2012-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>350513</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>FP7 Collaborative Project (Theme HEALTH) HYPERDIFF (3m euros across 7 participants)</gtr:description><gtr:end>2011-10-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>223585</gtr:fundingRef><gtr:id>A12694FC-1104-49C1-B3EF-0E6F6D7DC40A</gtr:id><gtr:outcomeId>ED50EE777A00</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>77000</gtr:amountPounds><gtr:country>Germany, Federal Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MERCK Investigators Award (Toxin A in Clostridium Difficile Disease)</gtr:description><gtr:end>2014-03-02</gtr:end><gtr:fundingOrg>Merck</gtr:fundingOrg><gtr:fundingRef>Purchase Ord No 8100395414</gtr:fundingRef><gtr:id>D1D1C24F-BBE8-4AEE-BA0B-9A489953A480</gtr:id><gtr:outcomeId>545cf9a47827b4.28812238</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3946605</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Horizon 2020</gtr:department><gtr:description>HORIZON2020 Marie Curie ETN, CLOSPORE</gtr:description><gtr:end>2018-02-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>642068</gtr:fundingRef><gtr:id>13ED4388-EDDD-4AAD-AD09-1AF46909895C</gtr:id><gtr:outcomeId>545e2fe9d21eb1.70979380</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>215418</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC funding (TSB) TS/G001790/1 PRADA (Portable Rapid Automated DNA Analysis)</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>TS/G001790/1</gtr:fundingRef><gtr:id>B0D5BE94-8E5B-47B3-9CE9-D87657128BEC</gtr:id><gtr:outcomeId>20773C531340</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>174128</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIH Award</gtr:description><gtr:end>2019-11-02</gtr:end><gtr:fundingOrg>National Institutes of Health Clinical Center</gtr:fundingOrg><gtr:id>AD4E4F91-C93C-456B-9444-C9AEBD566C72</gtr:id><gtr:outcomeId>56ba18927c0842.87517976</gtr:outcomeId><gtr:sector>Hospitals</gtr:sector><gtr:start>2014-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>20000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Donation - Research into Clostridium Difficile</gtr:description><gtr:end>2011-06-02</gtr:end><gtr:fundingOrg>Nottingham University Hospitals NHS Trust</gtr:fundingOrg><gtr:id>FAC5C81A-1363-4172-AF71-800A48621EA1</gtr:id><gtr:outcomeId>545cf9f46c59a5.38228408</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>15514</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>IPSEN Services Rendered contract</gtr:description><gtr:end>2016-11-02</gtr:end><gtr:fundingOrg>Ipsen</gtr:fundingOrg><gtr:id>6D24B033-C49A-44F6-9455-EBE2A33BFFC0</gtr:id><gtr:outcomeId>56ba1a4423b302.34580586</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4111621</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Marie Curie Initial Training Network (ITN)</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>Marie Sklodowska-Curie Actions</gtr:fundingOrg><gtr:fundingRef>215697-2</gtr:fundingRef><gtr:id>746A195E-F589-4E0E-AFB5-B7EC858F42EB</gtr:id><gtr:outcomeId>DBDFFF0DE980</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>369000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Pfizer - Asporogenic non-toxigenic strains of C.difficile</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Pfizer Global R &amp; D</gtr:fundingOrg><gtr:fundingRef>PO No 7Z4-N-3155606</gtr:fundingRef><gtr:id>AF4B560A-883C-401E-AA5D-2167914BC6B7</gtr:id><gtr:outcomeId>545cf5ae1fe4f8.07691987</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2009-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>109400</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC CASE Studentship PHICO THERAPEUTICS</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/K017829/1</gtr:fundingRef><gtr:id>BAC79590-73E8-4978-A420-C4289D3878FB</gtr:id><gtr:outcomeId>ipBW6idXnVx</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>56500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC CASE Studentship (Unilever)</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>CB9F7348-4AAF-497B-B45E-E0BD10542603</gtr:id><gtr:outcomeId>1531EDC0F060</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>7500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Biomedical Research Unit, Nottingham University Hospitals NHS Trust</gtr:department><gtr:description>Nottingham Digestive Diseases Centre Biomedical Research Unit (NDDC BRU)</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>443AB74E-B63D-45BD-8407-5644155E9CB6</gtr:id><gtr:outcomeId>aQm6JH6d7ts0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>49206</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Contract (Summit Plc)</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>Summit Plc</gtr:fundingOrg><gtr:id>6AA03213-A2D9-44B5-B8F0-D4F479129918</gtr:id><gtr:outcomeId>545e2beb862fa7.66029907</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>45000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC CASE Studentship (Novolytics)</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>7B030072-9C8E-4B4B-8A36-82A56E9AD704</gtr:id><gtr:outcomeId>4F927D2FAA30</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC DTA Studentship</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>CE323B2D-BD3B-4DE1-9C32-CF972EAC647F</gtr:id><gtr:outcomeId>HCSAvWuNs3H</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>17000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>VIP Award 2010/11 - David Burns</gtr:description><gtr:end>2011-03-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>092414/Z/10/Z</gtr:fundingRef><gtr:id>C49A5FB1-C649-4BB6-91DF-5C21F4205AF8</gtr:id><gtr:outcomeId>545cf8bfa88ed1.39170276</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>139997</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Pilot Industry Collaboration Award (PICA)</gtr:description><gtr:end>2011-05-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>7B822790-4A8B-49C5-83EA-8BE1B3B3DB76</gtr:id><gtr:outcomeId>37C4FCF370A0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>207000</gtr:amountPounds><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>SNSF Sinergia Programme (In vivo germination of Clostridium difficile endospores)</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Swiss National Science Foundation</gtr:fundingOrg><gtr:fundingRef>DECISION CRSII3_147603/1</gtr:fundingRef><gtr:id>8DB5D818-8182-436D-BD64-FBC4E1E8A408</gtr:id><gtr:outcomeId>545cfec0ea4095.77621935</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Creating mutants by allelic exchange in Clostridium difficile has yet to be reported, principally due to the lack of negative selection markers. We have developed such a marker and used it to demonstrate the creation of directed mutants (in-frame deletions, as well as SNPs) in 2 different strains of C.difficile.</gtr:description><gtr:grantRef>G0601176</gtr:grantRef><gtr:id>64CF621C-9BB0-4648-A0B1-D95A256EF1EB</gtr:id><gtr:impact>It existence led to an external contract with a major international pharamaceutical company to create specific mutants of C.difficile useful in the development of a vaccine.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>cw437wHqLuw</gtr:outcomeId><gtr:patentId>WO2010084349 Priority date: 22/01/2009, Priority number: GB901001.8</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Development of a Negative Selection marker for Allelic Exchange in Clostridium difficile</gtr:title><gtr:yearProtectionGranted>2009</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citation in Cell 'Leading Edge</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>D3340DBB-8A78-45A9-B4F1-4D48A17EA6F8</gtr:id><gtr:outcomeId>jz3dkYM2ThW</gtr:outcomeId><gtr:type>Citation in clinical reviews</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have designed and constructed a standardized Clostridium modular vector system using standardised components and parts, compriisng 18 modules which may be combined to yield 400 different vectors.</gtr:description><gtr:id>0196CF37-FE26-4C6B-873D-56B1FD70AA13</gtr:id><gtr:impact>The system has been extensively tested and we propose its adoption as a standard for the Clostridium research community, whom we invite to use and contribute to the system.</gtr:impact><gtr:outcomeId>E216DD5F276</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Modular Vector System</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://www.clostron.com/pMTL80000.php</gtr:url><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A transposon system for the generation of random mutants in Clostridium difficile</gtr:description><gtr:id>DFC4ABA2-3048-4EBC-A71C-E073E7918FBF</gtr:id><gtr:impact>Has been used to create a number of mutants defective in spore formation and germination.</gtr:impact><gtr:outcomeId>jZXJG47wu8Y</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>A Mariner Transposon</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The ClosTron is a universal gene knock-out system for the genus Clostridium. Based on the Sigma Aldrich Targetron, we have now removed all reliance on purchase of their kits through provision of a free algorithm for intron retargeting design and links to custom DNA synthesis at http://www.clostron.com</gtr:description><gtr:id>155BB27D-5023-453F-B292-E612A4B4C452</gtr:id><gtr:impact>Prior to the development of the ClosTron just a handful of mutants had been made in most clostridial species (3 in Clostridium difficile), and in some none at all. Thanks to the ClosTron, 100s of mutants have now been made. It is revolutionising clostridial molecular biology.</gtr:impact><gtr:outcomeId>56A7E902DCD</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>ClosTron</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://www.clostron.com</gtr:url><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>&amp;gt;3500 Tn916 insertions in C. difficile available to be screened in phenotypic assays</gtr:description><gtr:id>BEC387F4-AEA8-427A-B8C3-BC75F57DB9E7</gtr:id><gtr:impact>Identification of gene required for flagella development</gtr:impact><gtr:outcomeId>HMqmetFWkAj</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Tn916 insertion library</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>6280FB01-120B-4127-B8B5-D8308C12986D</gtr:id><gtr:title>The role of toxin A and toxin B in Clostridium difficile infection.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d6cae6a4e445eddd4759ac15693dbc1"><gtr:id>9d6cae6a4e445eddd4759ac15693dbc1</gtr:id><gtr:otherNames>Kuehne SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>UMPLx7CLsvh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60A912E8-CAD7-4190-85DB-387693610AE6</gtr:id><gtr:title>Inflammasome activation contributes to interleukin-23 production in response to Clostridium difficile.</gtr:title><gtr:parentPublicationTitle>mBio</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/063e2c817abffb3b2c72d49791837424"><gtr:id>063e2c817abffb3b2c72d49791837424</gtr:id><gtr:otherNames>Cowardin CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56cc4b884dd488.09786971</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4AC0EE6-2CA0-4BC4-91BC-7C8F20BF615D</gtr:id><gtr:title>In silico analysis of sequenced strains of Clostridium difficile reveals a related set of conjugative transposons carrying a variety of accessory genes.</gtr:title><gtr:parentPublicationTitle>Mobile genetic elements</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c16cb3b4a09c54c5e879247e24a3448"><gtr:id>9c16cb3b4a09c54c5e879247e24a3448</gtr:id><gtr:otherNames>Brouwer MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2159-2543</gtr:issn><gtr:outcomeId>pm_14867_27_22754747</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E9C0DE4-0DD6-45FD-A81D-86E9D183EAFE</gtr:id><gtr:title>The binary toxin CDT enhances Clostridium difficile virulence by suppressing protective colonic eosinophilia.</gtr:title><gtr:parentPublicationTitle>Nature microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/063e2c817abffb3b2c72d49791837424"><gtr:id>063e2c817abffb3b2c72d49791837424</gtr:id><gtr:otherNames>Cowardin CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2058-5276</gtr:issn><gtr:outcomeId>58b5689c4d87b7.41781329</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1B95DAE-129F-41AC-97C1-3CB81AD9156C</gtr:id><gtr:title>A modular system for Clostridium shuttle plasmids.</gtr:title><gtr:parentPublicationTitle>Journal of microbiological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc3ea8b792596825199735b6955a59a0"><gtr:id>bc3ea8b792596825199735b6955a59a0</gtr:id><gtr:otherNames>Heap JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0167-7012</gtr:issn><gtr:outcomeId>7872900CABA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74772EF3-33D8-44A0-98F3-7588B23659AA</gtr:id><gtr:title>The emergence of 'hypervirulence' in Clostridium difficile.</gtr:title><gtr:parentPublicationTitle>International journal of medical microbiology : IJMM</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29c0f654bb5f03a21f70047dbc553c01"><gtr:id>29c0f654bb5f03a21f70047dbc553c01</gtr:id><gtr:otherNames>Cartman ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1438-4221</gtr:issn><gtr:outcomeId>BP7FbqPkWBa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7E5C7D7-402E-4B40-9EDC-CF706333D086</gtr:id><gtr:title>A mariner-based transposon system for in vivo random mutagenesis of Clostridium difficile.</gtr:title><gtr:parentPublicationTitle>Applied and environmental microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29c0f654bb5f03a21f70047dbc553c01"><gtr:id>29c0f654bb5f03a21f70047dbc553c01</gtr:id><gtr:otherNames>Cartman ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0099-2240</gtr:issn><gtr:outcomeId>2C573A5DB41</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>206D8560-4237-434B-8D5A-34A8F86E73B3</gtr:id><gtr:title>Multiple factors modulate biofilm formation by the anaerobic pathogen Clostridium difficile.</gtr:title><gtr:parentPublicationTitle>Journal of bacteriology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e757fdcea0fb867c9a00abc2b6516898"><gtr:id>e757fdcea0fb867c9a00abc2b6516898</gtr:id><gtr:otherNames>?apa T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9193</gtr:issn><gtr:outcomeId>pm_14867_27_23175653</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>352D450F-171E-4357-9C04-90BFCFCEDE08</gtr:id><gtr:title>The role of flagella in Clostridium difficile pathogenicity.</gtr:title><gtr:parentPublicationTitle>Trends in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56175f0571a915ae580d3d0fdaee0348"><gtr:id>56175f0571a915ae580d3d0fdaee0348</gtr:id><gtr:otherNames>Stevenson E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0966-842X</gtr:issn><gtr:outcomeId>56cc4b8820bc10.55991539</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD046E01-065A-4F6E-A1BF-2A90E3865D10</gtr:id><gtr:title>Genetic organisation, mobility and predicted functions of genes on integrated, mobile genetic elements in sequenced strains of Clostridium difficile.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c16cb3b4a09c54c5e879247e24a3448"><gtr:id>9c16cb3b4a09c54c5e879247e24a3448</gtr:id><gtr:otherNames>Brouwer MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>WQQJd1tf88H</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A446E2BF-570E-4232-AEE6-39057890E957</gtr:id><gtr:title>ClosTron-mediated engineering of Clostridium.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d6cae6a4e445eddd4759ac15693dbc1"><gtr:id>9d6cae6a4e445eddd4759ac15693dbc1</gtr:id><gtr:otherNames>Kuehne SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>UdiUT72DCaF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5E35CF5-CA71-47A8-9DD3-64F48B026EF0</gtr:id><gtr:title>Development of Clostridium difficile R20291?PaLoc model strains and in&amp;nbsp;vitro methodologies reveals CdtR is required for the production of CDT to cytotoxic levels.</gtr:title><gtr:parentPublicationTitle>Anaerobe</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a16c14ab0b4e8ca6e6c9872206eb660e"><gtr:id>a16c14ab0b4e8ca6e6c9872206eb660e</gtr:id><gtr:otherNames>Bilverstone TW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1075-9964</gtr:issn><gtr:outcomeId>58b5689b5be673.68557046</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76495B20-5671-41AE-88D5-1C4C69487A13</gtr:id><gtr:title>Draft genome sequence of the nontoxigenic Clostridium difficile strain CD37.</gtr:title><gtr:parentPublicationTitle>Journal of bacteriology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c16cb3b4a09c54c5e879247e24a3448"><gtr:id>9c16cb3b4a09c54c5e879247e24a3448</gtr:id><gtr:otherNames>Brouwer MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9193</gtr:issn><gtr:outcomeId>pm_14867_27_22461557</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20984EFF-D32A-43B7-A933-BA5639A26196</gtr:id><gtr:title>Tn916-like genetic elements: a diverse group of modular mobile elements conferring antibiotic resistance.</gtr:title><gtr:parentPublicationTitle>FEMS microbiology reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42c40734d6ff9a89aff2216baa39fd88"><gtr:id>42c40734d6ff9a89aff2216baa39fd88</gtr:id><gtr:otherNames>Roberts AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0168-6445</gtr:issn><gtr:outcomeId>gp8Ma7xMbbY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CBB9A4A2-6566-432C-8019-01E96B982A07</gtr:id><gtr:title>Integration of DNA into bacterial chromosomes from plasmids without a counter-selection marker.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc3ea8b792596825199735b6955a59a0"><gtr:id>bc3ea8b792596825199735b6955a59a0</gtr:id><gtr:otherNames>Heap JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>doi_55f94a94aed8644e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35C27522-0AEB-41AD-95BC-F632DFBDCFAF</gtr:id><gtr:title>Expanding the repertoire of gene tools for precise manipulation of the Clostridium difficile genome: allelic exchange using pyrE alleles.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d39a207854a60c1064514aabbed9084"><gtr:id>5d39a207854a60c1064514aabbed9084</gtr:id><gtr:otherNames>Ng YK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14867_27_23405251</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>94C82C0F-4266-4522-B052-468D2086E5C4</gtr:id><gtr:title>Clostridium difficile secreted Pro-Pro endopeptidase PPEP-1 (ZMP1/CD2830) modulates adhesion through cleavage of the collagen binding protein CD2831.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7e23dd662bfe977006a71daf18ea7b7"><gtr:id>f7e23dd662bfe977006a71daf18ea7b7</gtr:id><gtr:otherNames>Hensbergen PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>56cc4b86cbd129.40221707</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BAEBCFC9-F44E-4E47-AA27-07AD4924C39E</gtr:id><gtr:title>Lipoprotein CD0873 is a novel adhesin of Clostridium difficile.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4207636eee144934e478fcf5415ceb5e"><gtr:id>4207636eee144934e478fcf5415ceb5e</gtr:id><gtr:otherNames>Kovacs-Simon A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>545cb8230c5a27.56132798</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0453AC6-34A0-440A-BA5F-0AA8065759E9</gtr:id><gtr:title>Behavior and target site selection of conjugative transposon Tn916 in two different strains of toxigenic Clostridium difficile.</gtr:title><gtr:parentPublicationTitle>Applied and environmental microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c7e8bbdf1d1964200e261c424d4e7ca"><gtr:id>6c7e8bbdf1d1964200e261c424d4e7ca</gtr:id><gtr:otherNames>Mullany P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0099-2240</gtr:issn><gtr:outcomeId>pm_14867_27_22267673</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>158A271E-5071-48ED-A9F9-C5EE476538D7</gtr:id><gtr:title>The analysis of para-cresol production and tolerance in Clostridium difficile 027 and 012 strains.</gtr:title><gtr:parentPublicationTitle>BMC microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/157bd4e8403eebcc421fec745d7e3778"><gtr:id>157bd4e8403eebcc421fec745d7e3778</gtr:id><gtr:otherNames>Dawson LF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1471-2180</gtr:issn><gtr:outcomeId>iXJPV717nR3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>907E3F45-7D14-498A-AF50-0393D9B2B15B</gtr:id><gtr:title>The role of flagella in Clostridium difficile pathogenesis: comparison between a non-epidemic and an epidemic strain.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ceef4a65febe016f3bf683eac42361ac"><gtr:id>ceef4a65febe016f3bf683eac42361ac</gtr:id><gtr:otherNames>Baban ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14867_27_24086268</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78161AB8-7FF4-4638-ACC3-E61E0504FF4D</gtr:id><gtr:title>Analysis of a Clostridium difficile PCR ribotype 078 100 kilobase island reveals the presence of a novel transposon, Tn6164.</gtr:title><gtr:parentPublicationTitle>BMC microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a7568a3e2edefc2c2259630c7dd28ec"><gtr:id>2a7568a3e2edefc2c2259630c7dd28ec</gtr:id><gtr:otherNames>Corver J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-2180</gtr:issn><gtr:outcomeId>pm_14867_27_22747711</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74CC7B1F-BC1C-4159-828B-FC5E03EEC456</gtr:id><gtr:title>Important role of class I heat shock genes hrcA and dnaK in the heat shock response and the response to pH and NaCl stress of group I Clostridium botulinum strain ATCC 3502.</gtr:title><gtr:parentPublicationTitle>Applied and environmental microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/509cfc005bf4458d76ef283ca764b7f5"><gtr:id>509cfc005bf4458d76ef283ca764b7f5</gtr:id><gtr:otherNames>Selby K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0099-2240</gtr:issn><gtr:outcomeId>dPoG6XERnrJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20466350-F4F3-4487-B736-D2885C0ED416</gtr:id><gtr:title>ClosTron-targeted mutagenesis.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc3ea8b792596825199735b6955a59a0"><gtr:id>bc3ea8b792596825199735b6955a59a0</gtr:id><gtr:otherNames>Heap JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>mCrEzadKHfN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A5A2180-8726-44FE-8E0A-88799FAEA5E2</gtr:id><gtr:title>Both, toxin A and toxin B, are important in Clostridium difficile infection.</gtr:title><gtr:parentPublicationTitle>Gut microbes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d6cae6a4e445eddd4759ac15693dbc1"><gtr:id>9d6cae6a4e445eddd4759ac15693dbc1</gtr:id><gtr:otherNames>Kuehne SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1949-0976</gtr:issn><gtr:outcomeId>hJ4axGebeT1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>512C0AB6-C97D-4696-BE09-FD6EF1FE5BAF</gtr:id><gtr:title>Improving the reproducibility of the NAP1/B1/027 epidemic strain R20291 in the hamster model of infection.</gtr:title><gtr:parentPublicationTitle>Anaerobe</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0e7dda135d0624e47df573f6c6c8315"><gtr:id>e0e7dda135d0624e47df573f6c6c8315</gtr:id><gtr:otherNames>Kelly ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1075-9964</gtr:issn><gtr:outcomeId>585d334d6f7165.63028114</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B349D9AB-95E9-4373-BA9B-E339493258F5</gtr:id><gtr:title>Reconsidering the sporulation characteristics of hypervirulent Clostridium difficile BI/NAP1/027.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f99888ddb132558995e37b5cc1803a60"><gtr:id>f99888ddb132558995e37b5cc1803a60</gtr:id><gtr:otherNames>Burns DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>cxFkfiVJLsS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C5AAD9A-066D-42B2-B07B-FBA37E9F33E7</gtr:id><gtr:title>Determination of the attP and attB sites of phage CD27 from Clostridium difficile NCTC 12727.</gtr:title><gtr:parentPublicationTitle>Journal of medical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6682b85c220c8c8bd534e7066c4856a9"><gtr:id>6682b85c220c8c8bd534e7066c4856a9</gtr:id><gtr:otherNames>Williams R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-2615</gtr:issn><gtr:outcomeId>pm_14867_27_23699063</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75218139-6459-47AC-A52A-D95B273DB7DB</gtr:id><gtr:title>Precise manipulation of the Clostridium difficile chromosome reveals a lack of association between the tcdC genotype and toxin production.</gtr:title><gtr:parentPublicationTitle>Applied and environmental microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29c0f654bb5f03a21f70047dbc553c01"><gtr:id>29c0f654bb5f03a21f70047dbc553c01</gtr:id><gtr:otherNames>Cartman ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0099-2240</gtr:issn><gtr:outcomeId>pm_14867_27_22522680</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9ED32C10-B760-4A3C-B947-790C0B6E76C8</gtr:id><gtr:title>The ClosTron: Mutagenesis in Clostridium refined and streamlined.</gtr:title><gtr:parentPublicationTitle>Journal of microbiological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc3ea8b792596825199735b6955a59a0"><gtr:id>bc3ea8b792596825199735b6955a59a0</gtr:id><gtr:otherNames>Heap JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0167-7012</gtr:issn><gtr:outcomeId>9CDED1BED61</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>367EE1B3-B260-4A0B-848B-8B5A9B507A3A</gtr:id><gtr:title>The cold-induced two-component system CBO0366/CBO0365 regulates metabolic pathways with novel roles in group I Clostridium botulinum ATCC 3502 cold tolerance.</gtr:title><gtr:parentPublicationTitle>Applied and environmental microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7cdd9c0e12b01eef8319056dd7fdc67"><gtr:id>f7cdd9c0e12b01eef8319056dd7fdc67</gtr:id><gtr:otherNames>Dahlsten E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0099-2240</gtr:issn><gtr:outcomeId>pm_14867_27_24162575</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A9D0B1F-6C61-4B61-8192-B3FE08CB5B35</gtr:id><gtr:title>Release of TcdA and TcdB from Clostridium difficile cdi 630 is not affected by functional inactivation of the tcdE gene.</gtr:title><gtr:parentPublicationTitle>Microbial pathogenesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5e1c0df9b855f69262f630a7e3a85e6"><gtr:id>e5e1c0df9b855f69262f630a7e3a85e6</gtr:id><gtr:otherNames>Olling A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0882-4010</gtr:issn><gtr:outcomeId>pm_14867_27_22107906</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58599CB4-5A12-40D3-A82E-3D46601B8A48</gtr:id><gtr:title>The diverse sporulation characteristics of Clostridium difficile clinical isolates are not associated with type.</gtr:title><gtr:parentPublicationTitle>Anaerobe</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f99888ddb132558995e37b5cc1803a60"><gtr:id>f99888ddb132558995e37b5cc1803a60</gtr:id><gtr:otherNames>Burns DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1075-9964</gtr:issn><gtr:outcomeId>qtbaWvhxLZ5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C572504E-7791-43AB-8EB2-E3765EBF9A5D</gtr:id><gtr:title>SleC is essential for germination of Clostridium difficile spores in nutrient-rich medium supplemented with the bile salt taurocholate.</gtr:title><gtr:parentPublicationTitle>Journal of bacteriology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f99888ddb132558995e37b5cc1803a60"><gtr:id>f99888ddb132558995e37b5cc1803a60</gtr:id><gtr:otherNames>Burns DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9193</gtr:issn><gtr:outcomeId>0705616092E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>764F49A2-032D-4C98-B7ED-AD09B89A5D6B</gtr:id><gtr:title>Fluoroquinolone resistance does not impose a cost on the fitness of Clostridium difficile in vitro.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4cddfca5798238915d01c9875c495e2"><gtr:id>c4cddfca5798238915d01c9875c495e2</gtr:id><gtr:otherNames>Wasels F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn><gtr:outcomeId>56cc4b88b39a77.97529531</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9BE63F15-5A78-481B-A9C9-7CF7B763224A</gtr:id><gtr:title>Inactivation of the dnaK gene in Clostridium difficile 630 ?erm yields a temperature-sensitive phenotype and increases biofilm-forming ability.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1326cbdc2b06cce80aa05967777ed537"><gtr:id>1326cbdc2b06cce80aa05967777ed537</gtr:id><gtr:otherNames>Jain S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a784c1ed32862.51128025</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03B86996-DDF8-446E-B823-FD9BA4441998</gtr:id><gtr:title>A genetic assay for gene essentiality in Clostridium.</gtr:title><gtr:parentPublicationTitle>Anaerobe</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a152f06c7b5c300083fbdfb850ff12cf"><gtr:id>a152f06c7b5c300083fbdfb850ff12cf</gtr:id><gtr:otherNames>Walker DJF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1075-9964</gtr:issn><gtr:outcomeId>585d33f6d34ae8.90543697</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C207D79-DDF3-40D4-9F5C-0CF5719A9D51</gtr:id><gtr:title>Functional Intestinal Bile Acid 7a-Dehydroxylation byAssociated with Protection fromInfection in a Gnotobiotic Mouse Model.</gtr:title><gtr:parentPublicationTitle>Frontiers in cellular and infection microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4aa84f0081a0a05c91b899ceb4452b5f"><gtr:id>4aa84f0081a0a05c91b899ceb4452b5f</gtr:id><gtr:otherNames>Studer N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2235-2988</gtr:issn><gtr:outcomeId>58b5689b92e819.83814571</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>609C6ED9-0A95-4753-812E-9F8A1F9E16B2</gtr:id><gtr:title>cspB encodes a major cold shock protein in Clostridium botulinum ATCC 3502.</gtr:title><gtr:parentPublicationTitle>International journal of food microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac61d89766325e5ffcc02fe9434f1c9f"><gtr:id>ac61d89766325e5ffcc02fe9434f1c9f</gtr:id><gtr:otherNames>S?derholm H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0168-1605</gtr:issn><gtr:outcomeId>eAX5zVG3ma4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F6C4F4F-320D-467E-8918-CCF9D661B974</gtr:id><gtr:title>What's a SNP between friends: The influence of single nucleotide polymorphisms on virulence and phenotypes of Clostridium difficile strain 630 and derivatives.</gtr:title><gtr:parentPublicationTitle>Virulence</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/83bb66f6995b24d5fb8aa5dd5ea107ce"><gtr:id>83bb66f6995b24d5fb8aa5dd5ea107ce</gtr:id><gtr:otherNames>Collery MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2150-5594</gtr:issn><gtr:outcomeId>58b5689c25fba0.13122812</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6914D449-F3F6-46C4-8AB4-00FEA7538825</gtr:id><gtr:title>Systems Biology of Clostridium</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59cf6b6b76d058ebc9d9362a07e0f6f0"><gtr:id>59cf6b6b76d058ebc9d9362a07e0f6f0</gtr:id><gtr:otherNames>CARTMAN S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>545d16d56ff428.51546855</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B6ED5138-30D2-4C8F-8511-D2610E846415</gtr:id><gtr:title>Different antibiotic resistance and sporulation properties within multiclonal Clostridium difficile PCR ribotypes 078, 126, and 033 in a single calf farm.</gtr:title><gtr:parentPublicationTitle>Applied and environmental microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cc8bc115cd948be5b92bc3ecba13658b"><gtr:id>cc8bc115cd948be5b92bc3ecba13658b</gtr:id><gtr:otherNames>Zidaric V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0099-2240</gtr:issn><gtr:outcomeId>pm_14867_27_23001653</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76B1E665-0240-4E4B-915B-18FF8E439061</gtr:id><gtr:title>Transposon mutagenesis in Clostridium difficile.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8731d14b5c607079d7e3753e072c4606"><gtr:id>8731d14b5c607079d7e3753e072c4606</gtr:id><gtr:otherNames>Hussain HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>RkFBvEkNSYF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C28D790-AFF8-416A-BF36-0398D487DA93</gtr:id><gtr:title>Clostridium difficile-mediated effects on human intestinal epithelia: Modelling host-pathogen interactions in a vertical diffusion chamber.</gtr:title><gtr:parentPublicationTitle>Anaerobe</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16da9594eedf0f15c85fe9f971d8e9c9"><gtr:id>16da9594eedf0f15c85fe9f971d8e9c9</gtr:id><gtr:otherNames>Jafari NV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1075-9964</gtr:issn><gtr:outcomeId>56cc4b861a9118.16170125</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB0CF870-3085-43A5-A664-1E74E0B37229</gtr:id><gtr:title>Construction of a nontoxigenic Clostridium botulinum strain for food challenge studies.</gtr:title><gtr:parentPublicationTitle>Applied and environmental microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f1578c587b44404570000049eefadc2"><gtr:id>2f1578c587b44404570000049eefadc2</gtr:id><gtr:otherNames>Bradshaw M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0099-2240</gtr:issn><gtr:outcomeId>83DB7EB9339</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FCC9778E-5701-477F-B7A1-BA948A087E58</gtr:id><gtr:title>Coinfection and Emergence of Rifamycin Resistance during a Recurrent Clostridium difficile Infection.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92d97b15d6c59589a344b0a5e4f8ea09"><gtr:id>92d97b15d6c59589a344b0a5e4f8ea09</gtr:id><gtr:otherNames>Stevenson EC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn><gtr:outcomeId>58b5689c6d98f1.94855535</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3DA91A6-9DD7-49FF-8813-BB026D10342D</gtr:id><gtr:title>Effect of subinhibitory concentrations of four commonly used biocides on the conjugative transfer of Tn916 in Bacillus subtilis.</gtr:title><gtr:parentPublicationTitle>The Journal of antimicrobial chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec90677b098faa4c3863064c0048f21b"><gtr:id>ec90677b098faa4c3863064c0048f21b</gtr:id><gtr:otherNames>Seier-Petersen MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0305-7453</gtr:issn><gtr:outcomeId>pm_14867_27_24092655</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F83C919F-68BE-42E5-9C22-7546F80604BF</gtr:id><gtr:title>The SOS Response Master Regulator LexA Is Associated with Sporulation, Motility and Biofilm Formation in Clostridium difficile.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f9a9cdb6fe39ca5502f551a1b56ed9c"><gtr:id>7f9a9cdb6fe39ca5502f551a1b56ed9c</gtr:id><gtr:otherNames>Walter BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56cc4b86929976.02749720</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22194B88-2995-4BF2-9E26-B8C3A03B25CD</gtr:id><gtr:title>Importance of toxin A, toxin B, and CDT in virulence of an epidemic Clostridium difficile strain.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d6cae6a4e445eddd4759ac15693dbc1"><gtr:id>9d6cae6a4e445eddd4759ac15693dbc1</gtr:id><gtr:otherNames>Kuehne SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>pm_14867_27_23935202</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B08AB419-2882-424B-BE2A-9739FCB3709A</gtr:id><gtr:title>Clostridium difficile modulates host innate immunity via toxin-independent and dependent mechanism(s).</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16da9594eedf0f15c85fe9f971d8e9c9"><gtr:id>16da9594eedf0f15c85fe9f971d8e9c9</gtr:id><gtr:otherNames>Jafari NV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>545d15d21be716.37156374</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A19DC1AD-4547-46EF-A593-0D338EBAA58D</gtr:id><gtr:title>Demonstration of conjugative transposon (Tn5397)-mediated horizontal gene transfer between Clostridium difficile and Enterococcus faecalis.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54c6a8ba4f9e37b98f3e80ec203cfef7"><gtr:id>54c6a8ba4f9e37b98f3e80ec203cfef7</gtr:id><gtr:otherNames>Jasni AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn><gtr:outcomeId>tkpTB2nF2rF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6D03FE1-E9B3-4419-8F67-97313905E040</gtr:id><gtr:title>Clostridium difficile Genome Editing Using pyrE Alleles.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bceef260ec19e34e64634408e3de9cb"><gtr:id>2bceef260ec19e34e64634408e3de9cb</gtr:id><gtr:otherNames>Ehsaan M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>58b5689c928090.13241633</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47DF52EF-80C7-40F5-87DF-2EEEB9BA0DAD</gtr:id><gtr:title>Spores of Clostridium difficile clinical isolates display a diverse germination response to bile salts.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21b7ebd16772c52e68041b5fc4a5787e"><gtr:id>21b7ebd16772c52e68041b5fc4a5787e</gtr:id><gtr:otherNames>Heeg D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14867_27_22384234</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B04C01B-0367-44B8-8939-7E716E06E4FB</gtr:id><gtr:title>Characterization of the impact of rpoB mutations on the in vitro and in vivo competitive fitness of Clostridium difficile and susceptibility to fidaxomicin.</gtr:title><gtr:parentPublicationTitle>The Journal of antimicrobial chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d6cae6a4e445eddd4759ac15693dbc1"><gtr:id>9d6cae6a4e445eddd4759ac15693dbc1</gtr:id><gtr:otherNames>Kuehne SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0305-7453</gtr:issn><gtr:outcomeId>5a784c1eabbd30.92249667</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6603A466-62EF-4C84-8C4D-21A3D66BE9E1</gtr:id><gtr:title>Comparison of culture based methods for the isolation of Clostridium difficile from stool samples in a research setting.</gtr:title><gtr:parentPublicationTitle>Anaerobe</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d5d677f068f81f17fb44f25043af48f"><gtr:id>1d5d677f068f81f17fb44f25043af48f</gtr:id><gtr:otherNames>Lister M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1075-9964</gtr:issn><gtr:outcomeId>56cc4b89059540.48906540</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3EDF437-CD63-42FE-B61F-FC11977D1579</gtr:id><gtr:title>Sporulation studies in Clostridium difficile.</gtr:title><gtr:parentPublicationTitle>Journal of microbiological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f99888ddb132558995e37b5cc1803a60"><gtr:id>f99888ddb132558995e37b5cc1803a60</gtr:id><gtr:otherNames>Burns DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0167-7012</gtr:issn><gtr:outcomeId>sXaxGAoZfKh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3071BBB2-1372-44B1-BE07-FC6A16416E06</gtr:id><gtr:title>The flagellin FliC of Clostridium difficile is responsible for pleiotropic gene regulation during in vivo infection.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e177cc38a44458f8e507e219fd9e00c"><gtr:id>9e177cc38a44458f8e507e219fd9e00c</gtr:id><gtr:otherNames>Barketi-Klai A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>545cd83db1a648.15871184</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>237D81DE-9951-4E17-89B6-86738E5A9CE3</gtr:id><gtr:title>A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile.</gtr:title><gtr:parentPublicationTitle>Microbiology (Reading, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/356584eed4dafe3e298bdbc5769d0972"><gtr:id>356584eed4dafe3e298bdbc5769d0972</gtr:id><gtr:otherNames>Donald RG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1350-0872</gtr:issn><gtr:outcomeId>pm_14867_27_23629868</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3C94C0A-4849-4B7E-9E38-5A1FDAB4C9DB</gtr:id><gtr:title>Horizontal gene transfer converts non-toxigenic Clostridium difficile strains into toxin producers.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c16cb3b4a09c54c5e879247e24a3448"><gtr:id>9c16cb3b4a09c54c5e879247e24a3448</gtr:id><gtr:otherNames>Brouwer MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>pm_14867_27_24131955</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BC41EEE-56B7-4A4D-9C6E-67AE859D0F19</gtr:id><gtr:title>Array comparative hybridisation reveals a high degree of similarity between UK and European clinical isolates of hypervirulent Clostridium difficile.</gtr:title><gtr:parentPublicationTitle>BMC genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/20cf04f183acd4f5ba29f20369cbd9bb"><gtr:id>20cf04f183acd4f5ba29f20369cbd9bb</gtr:id><gtr:otherNames>Marsden GL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1471-2164</gtr:issn><gtr:outcomeId>545cbef0ceb4b3.35862031</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2BC9A77-29FC-42EC-B778-473B5E6530F4</gtr:id><gtr:title>Clostridium difficile spore germination: an update.</gtr:title><gtr:parentPublicationTitle>Research in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f99888ddb132558995e37b5cc1803a60"><gtr:id>f99888ddb132558995e37b5cc1803a60</gtr:id><gtr:otherNames>Burns DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0923-2508</gtr:issn><gtr:outcomeId>FLjscTGHwjf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF31C374-EA6A-4E95-BC6F-7E0D2FD4E28E</gtr:id><gtr:title>Mobile genetic elements in Clostridium difficile and their role in genome function.</gtr:title><gtr:parentPublicationTitle>Research in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c7e8bbdf1d1964200e261c424d4e7ca"><gtr:id>6c7e8bbdf1d1964200e261c424d4e7ca</gtr:id><gtr:otherNames>Mullany P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0923-2508</gtr:issn><gtr:outcomeId>5675de781d55a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D73C776B-F03B-4428-AF82-EFBDD557F12F</gtr:id><gtr:title>ClosTron-mediated engineering of Clostridium.</gtr:title><gtr:parentPublicationTitle>Bioengineered</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d6cae6a4e445eddd4759ac15693dbc1"><gtr:id>9d6cae6a4e445eddd4759ac15693dbc1</gtr:id><gtr:otherNames>Kuehne SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2165-5979</gtr:issn><gtr:outcomeId>doi_55f94a94acddff2f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A18EDC6-333E-454A-B9C5-15263BD62C78</gtr:id><gtr:title>Clostridia: Molecular biology in the post-genomic era</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc3ea8b792596825199735b6955a59a0"><gtr:id>bc3ea8b792596825199735b6955a59a0</gtr:id><gtr:otherNames>Heap JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:isbn>978-1-904455-38-7</gtr:isbn><gtr:outcomeId>545d1b4f706872.68803270</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0601176</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>